Image guidance (IG) may permit higher radiotherapy (RT) doses (>65 Gy) after radical prostatectomy (RP) without increased toxicity, with improved accuracy and smaller margins. Conebeam (CBCT) allows IGRT with volumetric images. This study evaluated CBCT shifts and toxicity after conformal IGRT, compared to RT with port films.
Materials/Methods
After IRB approval, 68 consecutive patients who received post-RP RT (2005 RT ( -2009 ) with CBCT were identified. Median dose was 68.4 Gy (R 66.6-70.2) delivered with 4-field, conformal IGRT. Online CBCT images were acquired 3-5 times weekly and were automatically co-registered to reference CT based on pelvic anatomy. Corrective shifts were made for deviations ≥5 mm. A comparative group was comprised of 150 patients who received post-RP RT (1990 RT ( -2004 to a median of 64.8 Gy (R 59.4-68.4) with weekly port films. Genitourinary (GU) and gastrointestinal (GI) toxicity (RTOG grade (G) ≥ 2) was compared using Fisher's exact test and odds ratio (OR) computed by logistic regression adjusted for dose. Two-way interactions were also investigated.
Results
CBCT mean shifts (SD) for 1053 fractions were 2.8 mm (2.8), 2.0 mm (2.4) & 3.1 mm (2.9) in the left-right (LR), anterior-posterior (AP) & superior-inferior (SI) axes, respectively. Shifts ≥ 5 mm were required for 15%, 6% & 19% of fractions in the LR, AP & SI axes, respectively. Late toxicity was evaluable in 43 patients (median follow-up 15 mo., R 3-46) in the CBCT group and 135 (median 74 mo., R 3-168) in the control group. GU and GI toxicity was largely G0-1. No G4 toxicity was reported. G2 & G3 acute GU toxicity was experienced by 13% (n=9) & 2% (n=1) of patients in the CBCT group, respectively, while 13% (n=19) had G2 acute GU toxicity in the control group. G2 late GU toxicity was experienced by 7% (n=3) of patients in the CBCT group and 5% (n=7) in the control group. G2 acute GI toxicity was experienced by 13% (n=9) in the CBCT group and 15% (n=23) of controls. Late GI toxicity was G2 & G3 in 2% (n=1) & 2% (n=1) of patients in the CBCT group, respectively, while 1% (n=1) had G2 toxicity in the control group. Acute GU (Fisher p=0.67) and GI (p=0.84) toxicity was not significantly different between the two groups. There was no association between acute GI toxicity and CBCT (p=0.74). Increased odds of acute GU toxicity were observed for doses > 68.4 Gy (interaction p=0.02), which were only delivered in the IGRT group.
Conclusion
Rates of acute toxicity with CBCT-guided post-RP RT to 68.4 Gy were similar to treatment to 64.8 Gy without IGRT. The higher rate of acute GU toxicity with doses > 68.4 Gy suggests a potential role for IMRT. IGRT with CBCT is associated with mostly G0-1 toxicity and minimal grade ≥ 2, suggesting that CBCT is a safe IG strategy. Longer follow-up is desired to compare late toxicity.
